USD 25.72
(1.94%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 369.84 Million USD | 6.22% |
2023 | 348.19 Million USD | 40.03% |
2022 | 248.66 Million USD | 103.88% |
2021 | 121.96 Million USD | 27.89% |
2020 | 95.36 Million USD | 31.74% |
2019 | 72.38 Million USD | 12.02% |
2018 | 64.61 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q4 | 84.36 Million USD | -9.02% |
2024 FY | 335.11 Million USD | -3.76% |
2024 Q3 | 92.72 Million USD | 0.26% |
2024 Q1 | 90.74 Million USD | 2.62% |
2024 Q2 | 92.48 Million USD | 1.91% |
2023 Q3 | 85.58 Million USD | -1.37% |
2023 Q2 | 86.77 Million USD | -0.72% |
2023 FY | 348.19 Million USD | 40.03% |
2023 Q1 | 87.4 Million USD | 6.23% |
2023 Q4 | 88.43 Million USD | 3.33% |
2022 Q2 | 55.13 Million USD | 35.52% |
2022 Q1 | 40.68 Million USD | 15.24% |
2022 Q3 | 70.56 Million USD | 27.98% |
2022 FY | 248.66 Million USD | 103.88% |
2022 Q4 | 82.28 Million USD | 16.61% |
2021 Q2 | 29.3 Million USD | 9.41% |
2021 Q1 | 26.78 Million USD | 1.77% |
2021 Q3 | 30.57 Million USD | 4.35% |
2021 Q4 | 35.3 Million USD | 15.47% |
2021 FY | 121.96 Million USD | 27.89% |
2020 FY | 95.36 Million USD | 31.74% |
2020 Q3 | 23.78 Million USD | 0.59% |
2020 Q4 | 26.31 Million USD | 10.64% |
2020 Q2 | 23.64 Million USD | 9.37% |
2020 Q1 | 21.61 Million USD | 9.6% |
2019 FY | 72.38 Million USD | 12.02% |
2019 Q4 | 19.72 Million USD | 6.08% |
2019 Q1 | 16.96 Million USD | 0.0% |
2019 Q2 | 17.09 Million USD | 0.76% |
2019 Q3 | 18.59 Million USD | 8.75% |
2018 FY | 64.61 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
American Well Corporation | 786.9 Million USD | 53.0% |
Doximity, Inc. | 260.87 Million USD | -41.769% |
Evolent Health, Inc. | 531.68 Million USD | 30.439% |
MultiPlan Corporation | 564.07 Million USD | 34.434% |
Teladoc Health, Inc. | 2.09 Billion USD | 82.312% |
Veeva Systems Inc. | 1.25 Billion USD | 70.579% |